News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1657 results

US university treats cancer patients with CRISPR

US17-04-2019

The University of Pennsylvania has treated two cancer patients with CRISPR/Cas 9, a gene-editing technology that allows precise modifications to DNA.

Catalent to buy $1.2bn gene therapy company

US17-04-2019

Contract drug manufacturer Catalent has agreed to acquire Paragon Bioservices, a viral vector development and manufacturing partner for gene therapies, for $1.2 billion.

SCOTUS refuses to hear tribal immunity suit

US16-04-2019

The US Supreme Court has declined to hear a closely-watched case on tribal immunity involving pharmaceutical company Allergan and the Saint Regis Mohawk Tribe, a Native American tribe.

Fresenius files IPR against Amgen

US15-04-2019

Fresenius Kabi has submitted a petition for inter partes review of US patent number 9,856,287, a patent owned by Amgen.

Amgen appeals against PTAB Sanofi decision

US12-04-2019

Amgen subsidiary Immunex has appealed against a Patent Trial and Appeal Board decision which invalidated a patent claiming antibodies that target human interleukin-4 receptors.

FTC approves Fresenius’s $2bn acquisition of NxStage Medical

US10-04-2019

The US Federal Trade Commission has issued a final approval of Fresenius Medical Care’s $2 billion acquisition of medical device company NxStage Medical.

Duane Morris hires Winston & Strawn lawyer

Taiwan, US10-04-2019

Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.

Alnylam and Regeneron unveil RNAi partnership

US09-04-2019

Pharmaceutical companies Alnylam and Regeneron will collaborate on the development and commercialisation of RNA interference therapeutics.

Sun Pharma takes Pfizer to court over Lyrica

US08-04-2019

India-based drugmaker Sun Pharma has accused Pfizer of infringing a patent with a new extended-release formulation of Lyrica.

FDA boosts customs collaboration to fight fake drugs

US05-04-2019

The US Food and Drug Administration and US Customs and Border Protection have strengthened their collaboration in a bid to halt the import of counterfeit drugs and protect public health.

Showing 1 to 10 of 1657 results

LSIPR